First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
NCT06727981
·
clinicaltrials.gov ↗
RECRUITING
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Advanced Gastric Cancer
Locally Advanced Gastric Carcinoma
Interventions
DRUG:
ICI plus Chemothearpy
DRUG:
Chemotherapy
Sponsor
Qilu Hospital of Shandong University